Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1981 10
1982 23
1983 33
1984 31
1985 43
1986 63
1987 96
1988 102
1989 106
1990 82
1991 105
1992 194
1993 160
1994 220
1995 231
1996 220
1997 226
1998 264
1999 293
2000 276
2001 339
2002 401
2003 385
2004 418
2005 468
2006 473
2007 510
2008 521
2009 569
2010 592
2011 662
2012 670
2013 706
2014 703
2015 698
2016 671
2017 602
2018 574
2019 546
2020 658
2021 611
2022 525
2023 367
2024 121

Text availability

Article attribute

Article type

Publication date

Search Results

14,234 results

Results by year

Filters applied: . Clear all
The following terms were ignored: "", OR
Page 1
Multiple sclerosis.
Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG. Noseworthy JH, et al. N Engl J Med. 2000 Sep 28;343(13):938-52. doi: 10.1056/NEJM200009283431307. N Engl J Med. 2000. PMID: 11006371 Review. No abstract available.
Interferon beta-1b.
Goodkin DE. Goodkin DE. Lancet. 1994 Oct 15;344(8929):1057-60. doi: 10.1016/s0140-6736(94)91713-2. Lancet. 1994. PMID: 7934448 Review. No abstract available.
Interferon beta-1B--hope or hype?
[No authors listed] [No authors listed] Drug Ther Bull. 1996 Feb;34(2):9-11. doi: 10.1136/dtb.1996.3429. Drug Ther Bull. 1996. PMID: 8819985 Review. No abstract available.
Cotton wool spots associated with interferon beta-1 alpha therapy.
Longmuir R, Lee AG, Rouleau J. Longmuir R, et al. Semin Ophthalmol. 2007 Jan-Mar;22(1):49-53. doi: 10.1080/08820530601182725. Semin Ophthalmol. 2007. PMID: 17366120
PURPOSE: To describe a case of cotton wool spots associated with interferon beta-1a treatment. METHODS: Observational case report. RESULTS: A 40-year-old man with a history of multiple sclerosis was on interferon beta-1a. ...CONCLUSION: To our knowledg …
PURPOSE: To describe a case of cotton wool spots associated with interferon beta-1a treatment. METHODS: Observational case rep …
[Interferon beta 1-a in multiple sclerosis: 1-year experience in 62 patients].
Tilbery CP, Felipe E, Moreira MA, Mendes MF, França AS. Tilbery CP, et al. Arq Neuropsiquiatr. 2000 Jun;58(2B):452-9. doi: 10.1590/s0004-282x2000000300009. Arq Neuropsiquiatr. 2000. PMID: 10920406 Free article. Clinical Trial. Portuguese.
We report the results of a trial of interferon beta 1-a in 62 ambulatory patients with relapsing-remitting multiple sclerosis. ...The EDSS score in patients that did not take the mediaction was 4.7 and 2.0 for the patients with interferon beta 1-a. …
We report the results of a trial of interferon beta 1-a in 62 ambulatory patients with relapsing-remitting multiple sclerosis. …
Interferon beta-1b.
Rudge P. Rudge P. Lancet. 1994 Nov 26;344(8935):1511. doi: 10.1016/s0140-6736(94)90331-x. Lancet. 1994. PMID: 7968150 No abstract available.
Sarcoidosis associated with Interferon beta treatment.
García Ródenas MDM, Gayá García-Manso I, García Sevila R. García Ródenas MDM, et al. Med Clin (Barc). 2019 Sep 13;153(5):e21-e22. doi: 10.1016/j.medcli.2018.11.021. Epub 2019 Jan 2. Med Clin (Barc). 2019. PMID: 30611535 Review. English, Spanish. No abstract available.
Nebulised interferon beta-1a for patients with COVID-19.
Peiffer-Smadja N, Yazdanpanah Y. Peiffer-Smadja N, et al. Lancet Respir Med. 2021 Feb;9(2):122-123. doi: 10.1016/S2213-2600(20)30523-3. Epub 2020 Nov 12. Lancet Respir Med. 2021. PMID: 33189160 Free PMC article. No abstract available.
14,234 results
You have reached the last available page of results. Please see the User Guide for more information.